Salvage patients, those with colorectal metastases to the liver who do not to respond to both first and second lines of treatment, are responding significantly to radioembolization with Y-90 microspheres. The dual-action treatment has been shown to lead to more than 12 months of overall survival, according to a study published Nov. 1 in the Journal of Nuclear Medicine.

Given Imaging (NASDAQ: GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced that Japan's Central Social Insurance Medical Council (Chuikyo) has approved the recommendation by the Japanese Ministry of Health, Labor and Welfare (MHLW) to provide reimbursement for Given Imaging's PillCam COLON. With this approval, Chuikyo established a reimbursement of 83,100 JPY, or roughly $840.00 USD (using current exchange rate), per capsule that is scheduled to go into effect on January 1, 2014. This decision follows regulatory clearance of PillCam COLON in July of this year by Japan's Pharmaceuticals & Medical Devices Agency (PMDA). The MHLW will determine the final indication for use for PillCam COLON in December as well as the amount for the professional fee.

Claims research that examines particular conditions, patients with high utilization rates and physicians with high referral rates may advance the evidence base for quality improvement, according to a study published online Nov. 6 in The Journal of the American College of Radiology.

It is International Day of Radiology Nov. 8 and radiological societies and institutions around the world are commemorating historical benchmarks and technological advancements in the field.

RadNet Inc. (Nasdaq:RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 251 fully-owned and operated outpatient imaging centers, announced today that David W. Stoller, M.D., F.A.C.R. has joined its network of providers as the National Director of Orthopaedic and Musculoskeletal Imaging. Dr. Stoller will also serve as the Director of Orthopaedic and Musculoskeletal Imaging for the Northern California division of RadNet's affiliated radiology group, Beverly Radiology Medical Group.

The American Society of Clinical Oncology (ASCO) has released its top five list of tests, procedures, and treatments whose common use and clinical value are not supported by available evidence as part of the American Board of Internal Medicine’s Choosing Wisely Campaign.

Radiology is deploying new technology and techniques to tackle the obesity epidemic, —but image quality and radiation dose are still major challenges.

Cleveland Clinic Innovations has formed a spin-off company, Cleveland Diagnostics Inc., to develop and commercialize cancer diagnostics and screening tests.